Changes to the instructions for medical use of medicinal products

Professional development Vacancies
Changes to the instructions for medical use of medicinal products
Norvasc (amlodipine)

MoH of Ukraine Order No. 636 of 01.10.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Tantum Verde (benzydamine)

MoH of Ukraine Order No. 636 of 01.10.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Ursofalk (ursodeoxycholic acid)

MoH of Ukraine Order No. 649 of 02.10.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Telmisartan (Micardis)

MoH of Ukraine Order No. 614 of 21.09.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Aclasta (zoledronic acid)

MoH of Ukraine Order No. 578 of 04.09.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Motilium (domperidone)

MoH of Ukraine Order No. 578 of 04.09.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Copegus (ribavirin)

MoH of Ukraine Order No. 562 of 03.09.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Crestor (rosuvastatin)

MoH of Ukraine Order No. 562 of 03.09.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Lokren (betaxolol)

MoH of Ukraine Order No. 554 of 01.09.15 approved the instruction for medical use (hereinafter – the instruction) of the original (reference) medicinal product,…

Read more
Nurofen (ibuprofen)

By MoH orders No. 537 of 20.08.15 and No. 554 of 01.09.15, instructions for medical use were approved (hereinafter –…

Read more